One Stop Solution For In-Depth Market Research Reports

Home    >    HEALTHCARE AND PHARMACEUTICALS   >   Industrial Microbiology Market

Industrial Microbiology Market - Growth, Trends, and Forecasts (2020 - 2025)

Product Code : MDHC0089017
Survey : Mordor Intelligence
Publish On : 20, May, 2022
Category : Healthcare and Pharmaceuticals
Report format : PDF
Sales price option (consumption tax not included)
Single User USD4250 / Question Form
5 User USD4750 / Question Form
Enterprise User USD7500 / Question Form
 - 3M Company
- Agilent Technologies
- Becton Dickinson and Company
- BioMerieux SA
- Bio-Rad Laboratories Inc.
- Danaher Corporation
- Eppendorf AG
- Qiagen NV
- Sigma Aldrich (Merck KGaA)
- Thermo Fisher Scientific Inc.

[Report Description]

Several microorganisms are used in industrial microbiology, including laboratory-selected mutants, naturally occurring organisms, and genetically modified organisms (GMOs). Microbiology research and development is finding increasing application in oil and gas organizations, the food and beverage industry, and environmental testing organizations. In addition, the traditional R&D in the biopharmaceutical industry is witnessing an upsurge, due to drug development research, which is helping in the augmentation of the industrial microbiology market. Increased demand for nutraceuticals and other fermented products further drives the importance of industrial application of microbiology on a large scale. Such factors are helpful to drive the industrial market.

However, in the market, there are several conflicts observed regarding the usage of genetically modified organisms in food sources, which are expected to restrict the growth of the industrial microbiology market.

Key Market Trends

The Application in Pharmaceutical Industry is Expected to Witness Healthy Growth Over the Forecast period

Pharmaceutical microbiology is the applied branch of microbiology which allows pharmacists to manufacture pharmaceuticals from microorganisms either directly or with the use of some products produced by them. Other aspects of pharmaceutical microbiology include research and development for the manufacturing of various anti- tumors, anti-microbial agents.

Moreover, the global pharmaceutical industry investment in research and development has increased over the years, from USD 108.1 billion in 2006 to USD 156.7 billion in 2016, as per a 2017 report by the Association of the British Pharmaceutical Industry. Hence, with the increasing expenditure in R&D, the application of microbiology in the pharmaceutical industry is expected to attain good growth over the forecast period.

North America Has the Major Share in the Industrial Microbiology Market

The US industrial microbiology market is expected to be boosted, due to the rapid growth in various industries, like food and beverage, pharmaceutical, agricultural, environmental, and cosmetic. In Canada, as per the Canadian Society of Microbiologists, the applied and environmental microbiology researchers are engaged in various microbiological activities. A large number of applications supported by several companies’ investments, infrastructure development, and growing support from the United States Food and Drugs Administration (US FDA) and Canada Health are the major factors for the growth of the market. Mexico is also dependent on several items imports, especially from the US and Canada. This increases the demand and productions from the industrial microbiology industry in this region.

Competitive Landscape

There are several companies in this market across different geographical locations, which support different industries to grow at the domestic and international level. Some of the major players of this market include 3M Company, Becton Dickinson and Company, Bio-Rad Laboratories Inc., Thermo Fisher Scientific Inc., Sigma Aldrich (Merck KGaA), Qiagen NV, BioMerieux SA, Eppendorf AG, Danaher Corporation, and Sartorius AG, among others.

Reasons to Purchase this report:

- The market estimate (ME) sheet in Excel format
- 3 months of analyst support

1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study



4.1 Market Overview
4.2 Market Drivers
4.2.1 Growing Preference for Nutraceuticals and Other Fermented Products
4.2.2 Increasing R&D Expenditure and Increasing Innovation
4.2.3 Rising Concern for Food Safety
4.3 Market Restraints
4.3.1 Conflicts Regarding Usage Of Genetically Modified Organisms In Food Sources
4.3.2 Increasing Product Recalls
4.4 Porter's Five Forces Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry

5.1 By Product Type
5.1.1 Equipment and Systems
5.1.2 Consumables
5.1.3 Reagents
5.2 By Application Area
5.2.1 Food and Beverage Industry
5.2.2 Pharmaceutical Biotechnology Industry
5.2.3 Agricultural Industry
5.2.4 Environmental Industry
5.2.5 Cosmetic Industry or Personal Care Industry
5.2.6 Other Application Areas
5.3 Geography
5.3.1 North America United States Canada Mexico
5.3.2 Europe France Germany United Kingdom Italy Spain Rest of Europe
5.3.3 Asia-Pacific China Japan India Australia South Korea Rest of Asia-Pacific
5.3.4 Middle-East & Africa GCC South Africa Rest of Middle-East & Africa
5.3.5 South America Brazil Argentina Rest of South America

6.1 Company Profiles
6.1.1 3M Company
6.1.2 Agilent Technologies
6.1.3 Becton Dickinson and Company
6.1.4 BioMerieux SA
6.1.5 Bio-Rad Laboratories Inc.
6.1.6 Danaher Corporation
6.1.7 Eppendorf AG
6.1.8 Qiagen NV
6.1.9 Sigma Aldrich (Merck KGaA)
6.1.10 Thermo Fisher Scientific Inc.


Shibuya data count

Shibuya Data Count is a reseller offering a variety of market research reports from different industries, provided by a global team of experienced research professionals who ensure the most reliable and up-to-date research analysis reports.

Recommended reports